FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades

Eli Lilly won FDA approval for a migraine drug on Friday, giving the pharmaceutical giant a second medication that addresses the condition that causes millions of people to experience severe headaches and other debilitating symptoms.